
Tirzepatide · Batch 2026 · 99.699% purity
We prove quality with documents, not adjectives — independent third-party testing and a COA for every batch.
Each production batch is tested by an independent third-party laboratory using HPLC (for purity) and mass spectrometry (for identity). The resulting Certificate of Analysis reports the batch number, purity percentage, and method — so you can confirm quality yourself, not take our word for it.
Learn how to read a peptide COA → · See what “third-party tested” should prove →
Third-party reports for Certiva's 2026 Tirzepatide, Retatrutide, and Semaglutide batches.

Tirzepatide · Batch 2026 · 99.699% purity

Retatrutide · Batch 2026 · 99.699% purity

Semaglutide · Batch 2026 · 99.599% purity
Yes. Every production batch is third-party tested and issued a Certificate of Analysis (COA) reporting HPLC purity and identity, tied to a traceable batch number. We publish selected 2026 reports below and share matching documents for other batches on inquiry.
Identity and purity are verified by HPLC (High-Performance Liquid Chromatography) and mass spectrometry, performed by an independent third-party laboratory.
Yes. Each COA names the testing lab, batch number, method, and date, so the result can be cross-checked. The batch number on the COA matches the vial.
Research peptides typically report 98–99%+ HPLC purity, documented per batch on the COA. Exact figures are stated on each batch document.
Tell us the product and batch, and we'll send the matching Certificate of Analysis with your quote.
Before you go
Tell us what you're looking for and we'll send a sample COA and answer your inquiry — no obligation.